Moving Over the Contraceptive
As the Indian woman becomes more aware and vocal about her health, are pharma companies gearing up to meet her aspirations? For…
Author
Woman on a mission
An entrepreneur producing quality medicines, Leena Gandhi Tewari, Chairperson, USV, is also a humanitarian striving towards the…
Breakingthrough FDA
As women all across the world grapple with cancer, the oncology space is getting competitive with companies coming up with new…
‘Gender diversity and corporate boards’— Pharma leads the way!
Debabrat Mishra, Director, Hay Group India and Sudakshina Tyagi, Senior Consultant, Hay Group India elaborate on the need for more…
US FDA raises concerns over Lupin’s plant at Pithampur
FDA inspected the plant in January this year and listed six observations on the manufacturing processes at the plant
Lupin and Celon in agreement
Lupin and Celon Pharma have entered into a definitive agreement under which the companies will jointly develop fluticasone/…
Zydus completes phase I studies for its oral HIF inhibitor
The multiple dosing studies are expected to be completed by Q2 2015
Intas Pharmaceuticals launches biosimilar in Europe
The product has recently been introduced under the brand Accofil
Glenmark gets US approval for Ashlyna extended cycle oral contraceptive tablets
The company plans to commence shipping of Ashlyna immediately